カテゴリ： Research Dive, 世界, 医療/バイオ

3D細胞培養のグローバル市場2022-2031：スキャフォールドベース3D細胞培養、スキャフォールドなし3D細胞培養、マイクロ流体生体機能チップモデル

■ 英語タイトル：3D Cell Culture Market Product (Scaffold Based 3D Cell Culture, Scaffold Free 3D cell culture, and Microfluidic Organ-on-a-chip Models), Application (Cancer Research, Stem Cell Research, Drug Discovery & Development, and Regenerative Medicine), End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Hospitals, Diagnostic Centers, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2022-2031

調査会社Research Dive社が発行したリサーチレポート（データ管理コード：RDV23MA011）■ 発行会社/調査会社：Research Dive
■ 商品コード：RDV23MA011
■ 発行日：2022年12月4日
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[3D細胞培養のグローバル市場2022-2031：スキャフォールドベース3D細胞培養、スキャフォールドなし3D細胞培養、マイクロ流体生体機能チップモデル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Research Dive社によると、世界の3D細胞培養市場規模は2021年1,495.0百万ドルから2031年には5,656.7百万ドルまで、年平均15.07%の成長率を表すと見込まれます。本レポートでは、3D細胞培養の世界市場を調査・分析し、調査手法、調査範囲、エグゼクティブサマリー、市場概要、製品別（スキャフォールドベース3D細胞培養、スキャフォールドなし3D細胞培養、マイクロ流体生体機能チップモデル）分析、用途別（がん研究、幹細胞研究、創薬＆開発、再生医療）分析、エンドユーザー別（バイオテクノロジー＆製薬会社、受託研究所、病院、診断センター、学術機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況など、以下のようにまとめました。本書の参入企業情報としては、Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek, Hµrel Corporation, QGel SA, SynVivo, Advanced BioMatrix, Greiner Bio-One International, and Lonza.などがあります。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の3D細胞培養市場規模：製品別
- スキャフォールドベース3D細胞培養の市場規模
- スキャフォールドなし3D細胞培養の市場規模
- マイクロ流体生体機能チップモデルの市場規模
・世界の3D細胞培養市場規模：用途別
- がん研究用3D細胞培養の市場規模
- 幹細胞研究用3D細胞培養の市場規模
- 創薬＆開発用3D細胞培養の市場規模
- 再生医療用3D細胞培養の市場規模
・世界の3D細胞培養市場規模：エンドユーザー別
- バイオテクノロジー＆製薬会社における市場規模
- 受託研究所における市場規模
- 病院における市場規模
- 診断センターにおける市場規模
- 学術機関における市場規模
・世界の3D細胞培養市場規模：地域別
- 北米の3D細胞培養市場規模
- ヨーロッパの3D細胞培養市場規模
- アジア太平洋の3D細胞培養市場規模
- 中南米の3D細胞培養市場規模
- 中東/アフリカの3D細胞培養市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global 3D cell culture market is anticipated to generate a revenue of $5,656.7 million by 2031, increasing from $ 1,495.0 million in 2021, at a healthy CAGR of 15.07%.

COVID-19 Impact on the Global 3D Cell Culture Market:
The COVID-19 epidemic has caused nationwide lockdowns, affecting every industry. The pandemic also had an impact on the 3D cell culture sector. The industry is presently confronted with fresh issues in dealing with the demand-supply of 3D cell culture components. Furthermore, unpredictability and instability in supply chain operations, as well as labor shortages, are affecting the growth of the 3D cell culture market. In contrast, an increase in research & development processes for innovative COVID-19 therapies represents a big potential for the market’s leading competitors. Regenerative medicine research has yielded promising breakthroughs for treating the COVID-19 illness, and this is projected to compensate for the lethal impact caused by worldwide lockdowns. As a result, the COVID-19 impact is projected to remain a respectable opportunity for development for the major competitors in the 3D cell culture sector.

3D Cell Culture Market Analysis:
The 3D cell culture market is experiencing consistent growth as a result of factors such as the utilization of 3D cell culture models as alternative tools for in vivo testing, the development of large-scale automated cell culture systems, and the growing demand for organ transplantation. The 3D cell culture and co-culture models have significant advantages because they not only allow drug safety and efficacy assessment in a more in vivo-like context than traditional 2D cell cultures, but they can also eliminate species differences that pose limitations in the interpretation of preclinical outcomes by allowing drug testing directly in human systems. This factor is expected to drive the global 3D cell culture market growth.
However, the high cost of 3D cell culture may be a major factor in the market’s downturn. In addition, it is anticipated that a lack of trained pharmacists and lab technicians will restrict culture media market demand. During the projection period, all these issues are expected to reduce demand for cultural media.

In 3D cell culture, cells are grown in an environment that strongly matches the structure and function of native tissue. By interacting with their three-dimensional surrounds like they would in an in vivo setting, 3D cell culture techniques encourage cell differentiation, proliferation, and migration. This technology has several uses in drug screening, regenerative medicine, stem cell treatments, cancer research, and cell biology since 3D cell cultures may imitate the shape, activity, and milieu of in vivo tissues. Additionally, Micro fluidics in 3D cell culture has become able to generate microenvironments that facilitate tissue development and imitate the tissue-to-tissue contact, spatiotemporal chemical gradients, and mechanical microenvironments of live organs. This organ-on-a-chip model enables the study of human physiology in an organ-specific setting, enabling the development of in vitro disease models and ultimately serving as an adjunct to animal models in the development of drugs and the assessment of their toxicity.
Based on product, the scaffold-based 3D cell culture sub-segment is predicted to show the fastest growth by 2031, majorly due to the affordable prices and abundant reserves in various regions. The variables can be attributed to the benefits of scaffold-based 3D cell culture, such as the availability of connection sites and structural stiffness.

Based on application, the cancer research sub-segment is predicted to be the most dominant sub-segment by 2031 due to these factors, which can be made accountable for both the substantial spending for cancer research and the rise in incidence of the illness.
Based on end user, the biotechnology and pharmaceutical companies sub-segment is predicted to be the most dominant sub-segment by 2031 due to the increase factors that can be attributed to an increase in preference for alternative testing models over animal approaches, expanding R&D investment in these firms, and the existence of a significant number of pharmaceutical and biotechnology industries.
Based on geographical, the North America 3D cell culture market is anticipated to dominate market share in 2021. Increase in cancer incidence and the well-established pharmaceutical and biotechnology industries are significant drivers in the North American market’s growth.
The companies involved in the global 3D cell culture market are Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek, Hµrel Corporation, QGel SA, SynVivo, Advanced BioMatrix, Greiner Bio-One International, and Lonza.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global 3D cell culture market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on 3D Cell Culture Market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.3D cell culture market Analysis, by Product

5.1.Overview
5.2.Scaffold Based 3D Cell Culture

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region
5.2.3.Market share analysis, by country

5.3.Scaffold Free 3D cell culture

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region
5.3.3.Market share analysis, by country

5.4.Microfluidic Organ-on-a-chip Models

5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region
5.4.3.Market share analysis, by country

5.5.Research Dive Exclusive Insights

5.5.1.Market attractiveness
5.5.2.Competition heatmap

6.3D cell culture market Analysis, by Application

6.1.Cancer Research

6.1.1.Definition, key trends, growth factors, and opportunities
6.1.2.Market size analysis, by region
6.1.3.Market share analysis, by country

6.2.Stem Cell Research

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region
6.2.3.Market share analysis, by country

6.3.Drug Discovery & Development

6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region
6.3.3.Market share analysis, by country

6.4.Regenerative Medicine

6.4.1.Definition, key trends, growth factors, and opportunities
6.4.2.Market size analysis, by region
6.4.3.Market share analysis, by country

6.5.Research Dive Exclusive Insights

6.5.1.Market attractiveness
6.5.2.Competition heatmap

7.3D cell culture market Analysis, by End user

7.1.Biotechnology and Pharmaceutical Companies

7.1.1.Definition, key trends, growth factors, and opportunities
7.1.2.Market size analysis, by region
7.1.3.Market share analysis, by country

7.2.Contract Research Laboratories

7.2.1.Definition, key trends, growth factors, and opportunities
7.2.2.Market size analysis, by region
7.2.3.Market share analysis, by country

7.3.Hospitals, Diagnostic Centers, and Academic Institutes

7.3.1.Definition, key trends, growth factors, and opportunities
7.3.2.Market size analysis, by region
7.3.3.Market share analysis, by country

7.4.Research Dive Exclusive Insights

7.4.1.Market attractiveness
7.4.2.Competition heatmap

8.3D cell culture market, by Region

8.1.North America

8.1.1.U.S.

8.1.1.1.Market size analysis, by Product
8.1.1.2.Market size analysis, by Application
8.1.1.3.Market size analysis, by End user

8.1.2.Canada

8.1.2.1.Market size analysis, by Product
8.1.2.2.Market size analysis, by Application
8.1.2.3.Market size analysis, by End user

8.1.3.Mexico

8.1.3.1.Market size analysis, by Product
8.1.3.2.Market size analysis, by Application
8.1.3.3.Market size analysis, by End user

8.1.4.Research Dive Exclusive Insights

8.1.4.1.Market attractiveness
8.1.4.2.Competition heatmap

8.2.Europe

8.2.1.Germany

8.2.1.1.Market size analysis, by Product
8.2.1.2.Market size analysis, by Application
8.2.1.3.Market size analysis, by End user

8.2.2.UK

8.2.2.1.Market size analysis, by Product
8.2.2.2.Market size analysis, by Application
8.2.2.3.Market size analysis, by End user

8.2.3.France

8.2.3.1.Market size analysis, by Product
8.2.3.2.Market size analysis, by Application
8.2.3.3.Market size analysis, by End user

8.2.4.Spain

8.2.4.1.Market size analysis, by Product
8.2.4.2.Market size analysis, by Application
8.2.4.3.Market size analysis, by End user

8.2.5.Italy

8.2.5.1.Market size analysis, by Product
8.2.5.2.Market size analysis, by Application
8.2.5.3.Market size analysis, by End user

8.2.6.Rest of Europe

8.2.6.1.Market size analysis, by Product
8.2.6.2.Market size analysis, by Application
8.2.6.3.Market size analysis, by End user

8.2.7.Research Dive Exclusive Insights

8.2.7.1.Market attractiveness
8.2.7.2.Competition heatmap

8.3.Asia Pacific

8.3.1.China

8.3.1.1.Market size analysis, by Product
8.3.1.2.Market size analysis, by Application
8.3.1.3.Market size analysis, by End user

8.3.2.Japan

8.3.2.1.Market size analysis, by Product
8.3.2.2.Market size analysis, by Application
8.3.2.3.Market size analysis, by End user

8.3.3.India

8.3.3.1.Market size analysis, by Product
8.3.3.2.Market size analysis, by Application
8.3.3.3.Market size analysis, by End user

8.3.4.Australia

8.3.4.1.Market size analysis, by Product
8.3.4.2.Market size analysis, by Application
8.3.4.3.Market size analysis, by End user

8.3.5.South Korea

8.3.5.1.Market size analysis, by Product
8.3.5.2.Market size analysis, by Application
8.3.5.3.Market size analysis, by End user

8.3.6.Rest of Asia Pacific

8.3.6.1.Market size analysis, by Product
8.3.6.2.Market size analysis, by Application
8.3.6.3.Market size analysis, by End user

8.3.7.Research Dive Exclusive Insights

8.3.7.1.Market attractiveness
8.3.7.2.Competition heatmap

8.4.LAMEA

8.4.1.Brazil

8.4.1.1.Market size analysis, by Product
8.4.1.2.Market size analysis, by Application
8.4.1.3.Market size analysis, by End user

8.4.2.Saudi Arabia

8.4.2.1.Market size analysis, by Product
8.4.2.2.Market size analysis, by Application
8.4.2.3.Market size analysis, by End user

8.4.3.UAE

8.4.3.1.Market size analysis, by Product
8.4.3.2.Market size analysis, by Application
8.4.3.3.Market size analysis, by End user

8.4.4.South Africa

8.4.4.1.Market size analysis, by Product
8.4.4.2.Market size analysis, by Application
8.4.4.3.Market size analysis, by End user

8.4.5.Rest of LAMEA

8.4.5.1.Market size analysis, by Product
8.4.5.2.Market size analysis, by Application
8.4.5.3.Market size analysis, by End user

8.4.6.Research Dive Exclusive Insights

8.4.6.1.Market attractiveness
8.4.6.2.Competition heatmap

9.Competitive Landscape

9.1.Top winning strategies, 2021

9.1.1.By strategy
9.1.2.By year

9.2.Strategic overview

9.3.Market share analysis, 2021

10.Company Profiles

10.1.Corning Incorporated

10.1.1.Overview
10.1.2.Business segments
10.1.3.Product portfolio
10.1.4.Financial performance
10.1.5.Recent developments
10.1.6.SWOT analysis
10.1.7.Research Dive Analyst View

10.2.Thermo Fisher Scientific

10.2.1.Overview
10.2.2.Business segments
10.2.3.Product portfolio
10.2.4.Financial performance
10.2.5.Recent developments
10.2.6.SWOT analysis
10.2.7.Research Dive Analyst View

10.3.3D Biotek

10.3.1.Overview
10.3.2.Business segments
10.3.3.Product portfolio
10.3.4.Financial performance
10.3.5.Recent developments
10.3.6.SWOT analysis
10.3.7.Research Dive Analyst View

10.4.TissUse GmbH

10.4.1.Overview
10.4.2.Business segments
10.4.3.Product portfolio
10.4.4.Financial performance
10.4.5.Recent developments
10.4.6.SWOT analysis
10.4.7.Research Dive Analyst View

10.5.Hµrel Corporation

10.5.1.Overview
10.5.2.Business segments
10.5.3.Product portfolio
10.5.4.Financial performance
10.5.5.Recent developments
10.5.6.SWOT analysis
10.5.7.Research Dive Analyst View

10.6.QGel SA

10.6.1.Overview
10.6.2.Business segments
10.6.3.Product portfolio
10.6.4.Financial performance
10.6.5.Recent developments
10.6.6.SWOT analysis
10.6.7.Research Dive Analyst View

10.7.SynVivo

10.7.1.Overview
10.7.2.Business segments
10.7.3.Product portfolio
10.7.4.Financial performance
10.7.5.Recent developments
10.7.6.SWOT analysis
10.7.7.Research Dive Analyst View

10.8.Advanced BioMatrix

10.8.1.Overview
10.8.2.Business segments
10.8.3.Product portfolio
10.8.4.Financial performance
10.8.5.Recent developments
10.8.6.SWOT analysis
10.8.7.Research Dive Analyst View

10.9.Greiner Bio-One International

10.9.1.Overview
10.9.2.Business segments
10.9.3.Product portfolio
10.9.4.Financial performance
10.9.5.Recent developments
10.9.6.SWOT analysis
10.9.7.Research Dive Analyst View

10.10.Lonza

10.10.1.Overview
10.10.2.Business segments
10.10.3.Product portfolio
10.10.4.Financial performance
10.10.5.Recent developments
10.10.6.SWOT analysis
10.10.7.Research Dive Analyst View

11.Appendix

11.1.Parent & peer market analysis
11.2.Premium insights from industry experts
11.3.Related reports



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 3D細胞培養のグローバル市場（～2030年）：スキャフォールドベース3D細胞培養、スキャフォールドフリー3D細胞培養、3Dバイオリアクター、3Dシャーレ
  • 歯科用機器のグローバル市場2022-2031：修復、歯周、歯内療法、歯科矯正、その他
  • ハイドロコロイドドレッシングのグローバル市場2022-2031：急性創傷、慢性創傷、褥瘡
  • 外付け排尿管理製品のグローバル市場2022-2031：男性、女性
  • 凝固検査のグローバル市場2022-2031：器具、消耗品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(RDV23MA011 )"3D細胞培養のグローバル市場2022-2031：スキャフォールドベース3D細胞培養、スキャフォールドなし3D細胞培養、マイクロ流体生体機能チップモデル" (英文：3D Cell Culture Market Product (Scaffold Based 3D Cell Culture, Scaffold Free 3D cell culture, and Microfluidic Organ-on-a-chip Models), Application (Cancer Research, Stem Cell Research, Drug Discovery & Development, and Regenerative Medicine), End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Hospitals, Diagnostic Centers, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2022-2031)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。